Li Yan
Chief Tech/Sci/R&D Officer at Brii Biosciences Ltd.
Profile
Li Yan is currently the Chief Medical Officer at Brii Biosciences Ltd.
He previously worked as the Vice President at GSK Plc.
Prior to that, he was the Chief Medical Officer at Brii Biosciences Ltd.
(China) from 2018 to 2023.
Dr. Yan received his doctorate degree from the University of Kansas in 1996 and his undergraduate degree from Peking University Health Science Center in 1991.
Li Yan active positions
| Companies | Position | Start |
|---|---|---|
Brii Biosciences Ltd.
 Brii Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Brii Biosciences Ltd. is a biotechnology company, which engages in the provision of healthcare solutions. It focuses on the development of therapies for infectious diseases such as hepatitis B, COVID-19, human immunodeficiency virus (HIV) infection, multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases. The company was founded by Zhi Hong in 2018 and is headquartered in Durham, NC. | Chief Tech/Sci/R&D Officer | - |
Former positions of Li Yan
| Companies | Position | End |
|---|---|---|
| BRII BIOSCIENCES LIMITED | Chief Tech/Sci/R&D Officer | 05/07/2023 |
| GSK PLC | Corporate Officer/Principal | - |
Training of Li Yan
| University of Kansas | Doctorate Degree |
| Peking University Health Science Center | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| GSK PLC | Health Technology |
| BRII BIOSCIENCES LIMITED | Commercial Services |
| Private companies | 1 |
|---|---|
Brii Biosciences Ltd.
Brii Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Brii Biosciences Ltd. is a biotechnology company, which engages in the provision of healthcare solutions. It focuses on the development of therapies for infectious diseases such as hepatitis B, COVID-19, human immunodeficiency virus (HIV) infection, multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases. The company was founded by Zhi Hong in 2018 and is headquartered in Durham, NC. | Health Technology |
- Stock Market
- Insiders
- Li Yan
